Uso de CPAP nasal en el largo plazo en síndrome de apnea-hipopnea del sueño

Background: The use of CPAP is the conventional therapy for the Obstructive Sleep Apnea Syndrome (OSAS). Aim To establish the proportion of OSAS patients with CPAP indication who use it in the long-term and to determine predictive factors of adherence. Patients and Methods: Structured survey through...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Santín M,Julia, Jorquera A,Jorge, Jordán,Javiera, Bajut,Fawsia, Masalán A,Patricia, Mesa L,Tomás, Kuester F,Gisela, Godoy F,Jaime
Lenguaje:Spanish / Castilian
Publicado: Sociedad Médica de Santiago 2007
Materias:
Acceso en línea:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872007000700005
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:scielo:S0034-98872007000700005
record_format dspace
spelling oai:scielo:S0034-988720070007000052007-09-06Uso de CPAP nasal en el largo plazo en síndrome de apnea-hipopnea del sueñoSantín M,JuliaJorquera A,JorgeJordán,JavieraBajut,FawsiaMasalán A,PatriciaMesa L,TomásKuester F,GiselaGodoy F,Jaime CPAP ventilation Sleep apnea, obstructive therapeutics Background: The use of CPAP is the conventional therapy for the Obstructive Sleep Apnea Syndrome (OSAS). Aim To establish the proportion of OSAS patients with CPAP indication who use it in the long-term and to determine predictive factors of adherence. Patients and Methods: Structured survey through personal interview or phone call, applied to all patients who had polisomnographically documented OSAS and CPAP titration at the Pontificia Universidad Católica de Chile Sleep Disorders Center between January 1998 and November 2001. Patients were divided in "Permanent Users" (Group I) and "Non Users" (Group II). Results: Of 440 patients that fulfilled inclusion criteria, 162 (32.8%) answered the survey. Seventy percent (114/162) of these patients had used CPAP and 86% (98/114) continued to use it at the time of the interview, with a mean follow-up of 12.3 months (Group I 60.5% of the interviewed population). Group II included 64 patients (39.5% of the interviewed patients). Among the latter, 25% (16/64) stopped using CPAP due to intolerance, 25% (16/64) could not use it because of economical restrictions, 20.5% (13/64) preferred other therapies and 29.5% (15/64) merely refused treatment. Predictors of long-term use of CPAP were number of respiratory events (p <0.01), hypersomnolence (p <0.01) and age (p =0.03). Conclusions: Approximately two thirds of patients with OSAS, with an indication for CPAP, continue to use this therapy in the long term in a Chilean population. This figure is similar to other reports from abroad. It is also possible to identify predictive factors for CPAP discontinuation in this populationinfo:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.135 n.7 20072007-07-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872007000700005es10.4067/S0034-98872007000700005
institution Scielo Chile
collection Scielo Chile
language Spanish / Castilian
topic CPAP ventilation
Sleep apnea, obstructive
therapeutics
spellingShingle CPAP ventilation
Sleep apnea, obstructive
therapeutics
Santín M,Julia
Jorquera A,Jorge
Jordán,Javiera
Bajut,Fawsia
Masalán A,Patricia
Mesa L,Tomás
Kuester F,Gisela
Godoy F,Jaime
Uso de CPAP nasal en el largo plazo en síndrome de apnea-hipopnea del sueño
description Background: The use of CPAP is the conventional therapy for the Obstructive Sleep Apnea Syndrome (OSAS). Aim To establish the proportion of OSAS patients with CPAP indication who use it in the long-term and to determine predictive factors of adherence. Patients and Methods: Structured survey through personal interview or phone call, applied to all patients who had polisomnographically documented OSAS and CPAP titration at the Pontificia Universidad Católica de Chile Sleep Disorders Center between January 1998 and November 2001. Patients were divided in "Permanent Users" (Group I) and "Non Users" (Group II). Results: Of 440 patients that fulfilled inclusion criteria, 162 (32.8%) answered the survey. Seventy percent (114/162) of these patients had used CPAP and 86% (98/114) continued to use it at the time of the interview, with a mean follow-up of 12.3 months (Group I 60.5% of the interviewed population). Group II included 64 patients (39.5% of the interviewed patients). Among the latter, 25% (16/64) stopped using CPAP due to intolerance, 25% (16/64) could not use it because of economical restrictions, 20.5% (13/64) preferred other therapies and 29.5% (15/64) merely refused treatment. Predictors of long-term use of CPAP were number of respiratory events (p <0.01), hypersomnolence (p <0.01) and age (p =0.03). Conclusions: Approximately two thirds of patients with OSAS, with an indication for CPAP, continue to use this therapy in the long term in a Chilean population. This figure is similar to other reports from abroad. It is also possible to identify predictive factors for CPAP discontinuation in this population
author Santín M,Julia
Jorquera A,Jorge
Jordán,Javiera
Bajut,Fawsia
Masalán A,Patricia
Mesa L,Tomás
Kuester F,Gisela
Godoy F,Jaime
author_facet Santín M,Julia
Jorquera A,Jorge
Jordán,Javiera
Bajut,Fawsia
Masalán A,Patricia
Mesa L,Tomás
Kuester F,Gisela
Godoy F,Jaime
author_sort Santín M,Julia
title Uso de CPAP nasal en el largo plazo en síndrome de apnea-hipopnea del sueño
title_short Uso de CPAP nasal en el largo plazo en síndrome de apnea-hipopnea del sueño
title_full Uso de CPAP nasal en el largo plazo en síndrome de apnea-hipopnea del sueño
title_fullStr Uso de CPAP nasal en el largo plazo en síndrome de apnea-hipopnea del sueño
title_full_unstemmed Uso de CPAP nasal en el largo plazo en síndrome de apnea-hipopnea del sueño
title_sort uso de cpap nasal en el largo plazo en síndrome de apnea-hipopnea del sueño
publisher Sociedad Médica de Santiago
publishDate 2007
url http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872007000700005
work_keys_str_mv AT santinmjulia usodecpapnasalenellargoplazoensindromedeapneahipopneadelsueno
AT jorqueraajorge usodecpapnasalenellargoplazoensindromedeapneahipopneadelsueno
AT jordanjaviera usodecpapnasalenellargoplazoensindromedeapneahipopneadelsueno
AT bajutfawsia usodecpapnasalenellargoplazoensindromedeapneahipopneadelsueno
AT masalanapatricia usodecpapnasalenellargoplazoensindromedeapneahipopneadelsueno
AT mesaltomas usodecpapnasalenellargoplazoensindromedeapneahipopneadelsueno
AT kuesterfgisela usodecpapnasalenellargoplazoensindromedeapneahipopneadelsueno
AT godoyfjaime usodecpapnasalenellargoplazoensindromedeapneahipopneadelsueno
_version_ 1718436328964620288